PRINCETON, N.J.--(BUSINESS WIRE)--PharmaNet Development Group, Inc. (the “Company”) (NASDAQ: PDGI), a leading provider of clinical development services, today reported net income for the second quarter ended June 30, 2008, of $2.2 million, or $0.11 per diluted share, compared to a net loss from continuing operations of $4.6 million, or $0.25 per diluted share, in the second quarter 2007.
